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THE NATURE OF THE INHIBITION AND ACTIVATION OF EPIDERMAL 
PHOSPHOFRUCTOKINASE: AN ALLOSTERIC ENZYME* 
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ABSTRACT-! 
Phosphofructokinase (PFK) was pa rtia lly purifi ed ( x 50) from rhesus monkey epiderm is. 
Kineti c studi es showed a biphasic regula ti on of this enzy me by ATP, i.e., activation at low 
concent ration and inhibition at hi gh concentrat ions . The pa rt ia ll y purified PFK was in -
hibited by ATP at a final concentration well below the physiol ogic intracellula r leve l. 
Thi s feedback inhibition was counteracted by cyc li c 3' ,5 ' -AMP. 5'-AMP, ADP and P i; 
moreove r Pi plus one of' these aden ine nucl eotides showed marked synergis t ic effects . Epi -
derma l PFK was a lso inhibi ted by citrate and the inhibi t ion was released by cycl ic 3' , 5' -
AMP, 5' -AMP, a nd P i. T he initia l veloc it y of the PFK reaction pl otted against a varia ble 
s ubstra te (F6P) leve l y ielded a s igmoid curve, characteristic of a regulatory a llosteri c en -
zyme (H ill coeffi cien t "n" > 1). This a llosteric cha racteri st ic was strengthened at higher 
ATP concentrations and wea kened a t lower ATP leve ls . The a llosteri c nature was lost by 
t he additi on of' cyc li c 3' ,5'-AMP (i.e .. Hill coe ffi cient "'n " - · 1). These kinetic data indicate 
t ha t in the rhesus epidermis PFI< is a key en zy me that regu la tes glycolys is . 
Phosphofru c tokinase ( ATP: D-fru ctose-6-P- l -
phos photransferase. E C 2.7 .1.11) (PFK) cata lyzes 
the reaction: 
F-6-P + ATP ~ F-1,6-diP + ADP 
In severa l kinds of ma mma lia n t issues a nd 
microo rga ni sms, t he rate of t he conversion of F-6-
p to F-1,6-d iP, i. e., the cata lys is by PFK, ap-
pea rs to cont rol the overa ll rate of conversion of 
G-6-P to pyruva te via the Embd en- Meyerhof' 
pathway (1 , :2). Histori ca lly, the physiologic s ig-
nifica n ce of PFK as a rate- limiting enzy me had 
already been sugges ted in the 1940s by Cori (3), 
who pointed out that in muscle the leve l of hex-
ose m o nophospha te changes rapidly relat ive to the 
rate o f lacti c ac id forma tion a nd ca rbohydra te 
oxidation under ex perim ental condi tions (e.g. , 
mus cle contractio n). Later Lynen eta! (4) showed 
that anoxia ca uses a rapid decrease of hexosemon-
oph osphate a nd a n increase of hexosediphos phate . 
T heir data a lso indi cated a ra pid activation of 
PFK after a noxia. Lowry et a l (5) demonstrated 
clea rly that ischem ia causes a decrease of G-6-P 
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t The foll owing co mm on a bhrevations are used: 
G6P = glu cose-6-phosphate: PGP = l'ru ctose-6-phos-
phate ; P- t. G- diP = l'ru ctose- l. G-diph,Jsphat.e ; ATP = 
aden os ine triphosphate: ADP adenose diphos-
phate; AMP = adenos ine mnnoph osphate: NAD · (a nd 
NADH) = ni cotinamid e adenine d inu cleotid e. oxidized 
(and r e duced); Pi = orthophospha te. 
a nd F-6-P a nd an increase of F -1, 6-diP in the 
brain. 
In contrast to the indirect ev idence cited above, 
whi ch was based on acute cha nges in substrate 
levels after stress, a more direct proof for the key 
role played by PFK was reported by Mansour (6) , 
who showed that in the liver fluke Fascio la he-
pa tica. se rotonin stimulates both gl~· co l ys i s and 
PFK act ivitv . The se rotonin activation of the 
P FK is actua,ll .v mediated by cyc li c :3'. 5'-A MP (7). 
Mansour was a lso proba bly the firs t to purify 
PFK successfull y for va ri ous kinetic studi es in t he 
1960s (8) . Before that t ime, the purification of 
this enzyme was ha mpered by its marked insta -
bility. T he kinetics of purifi ed PFK display many 
properti es assoc iated with a typ ica l a ll oste ri c 
enzy me (8) . For exa mple, in hea rt muscle prepa-
ration Mansour showed tha t titra ti on of t he en -
zy me with F -6-P results in a s igmoida l saturat ion 
curve, indicative of a llost eric cont rol (1 , 2, 9- 11). 
ATP as well as cit rate (1:2) was found to inhibit 
t hi s enzy me, whereas fructose phosphate, AMP, 
and cyclic 3', 5' -AMP counteracted the inhi bition. 
S ince ATP ca n be consid ered t he end product of 
the glucose pathway , we can conclude t hat the 
PFK ste p is regu lated by a feedback cont rol in 
glycolysis through the end-product inhibi t ion by 
ATP (a nd citrate). Thus, when glucose oxidation 
becomes excessive, t he end products inhibi t PFK 
so t hat fl ow t hrough t he Embden - M eyerhof 
pathway dec reases . In other words, t he PFK reac-
t ion is prima rily res ponsible for t he Pasteur effect 
(l , 2, 12, 13). 
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In a prev ious communication (14) we reported 
an indirect demonstration of PFK activation in 
the epid ermis and s kin appendages . The present 
paper is conce rned wi th direct kin etic stud ies on 
purifi ed PFK from t he epidermis of rhesus mon-
keys . 
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MATERIALS AND METHODS 
Epiderm is was removed from nea rly t he enti re body 
surface, except fo r the face and sca lp, of adult rhesus 
monkeys (within 30 min po t-mortem) with a Castro-
viejo keratome adjusted to 0.1 mm thickness. T he epi-
dermal s lices were stored in 75% saturated ammonium 
sulfate adjusted to pH 7.5 wit h KOH at 0 to 4°C for not 
over 2 weeks (15). T he rest of the purificat ion proce-
dures (16) were done at 4 °C, unless otherwise s tated. 
Nine gram of ep idermis thus collected were homog-
eni zed with 50 m l of Ca · ·- free Krebs- Ringer phos-
phate buffer in a glass homogenize r. The homogenate 
was centri fuged at 28,000 x g for 15 min, a nd the super-
natant fract ion and precipitate were separated. Solid 
ammonium sulfate was added to the supernata nt frac -
t ion to y ield a 20% final concent rat ion (35% saturation) 
and the mixture was stir red for 15 min and centrifuged 
at 28,000 x g for 30 min. The precipitate was disca rded 
and solid ammonium sulfate was added to the superna-
ta nt fraction to y ield a 50% satu rat ion; the mixture was 
st irred fo r 15 min and aga in cent rifuged at 28,000 x g 
for 30 min and t he supernatant fraction was disca rded . 
The fina l precipitate was dissolved in 1 ml of AMP-
buffer (50 mM phosphate buffer, pH 7.5, conta inin g 0.1 
mM ATP and 5 mM MgSO.) , and appli ed to t he top of 
a Sepha dex G-200 column (1 x 26 em) .previously equi l-
ibra ted with the AMP-buffer. T he enzyme was elu ted 
with t he same buffer at a fl ow rate of about 10 ml/h r, 
and 1.5-m l fractions were collected in test tubes in to 
each of which we had previously added 100 JLI of 0.2 M 
cl.ithiothreitol to stab il ize t he purified enzyme. T he puri -
fied enzyme solu t ion (Fract ions 12, 13 and 14, cf. Fig. 1) 
was stored in sma ll test tubes a nd kept at 4°C, s ince in 
this condition it is stab le for a week but becomes inact i-
vated very rapidly otherwise (e.g., freezing at - 20°C 
causes rapid inactivation). 
PFK activit ies were assayed at room tem perature 
with a Farrand flu orometer wit h an attached recorder 
according to t he method of Hacker (17) modified by 
Hoskins and Stephens (16); t he latter modificat ion (3-
m! sca le) was further adapted to a 1-ml reaction sca le 
for maximum utilization of the purified enzyme. Reac-
tion rates were calculated from t he linea r portion of the 
record ing graph. Protein was determ ined by t he method 
of Lowry et a! ( 18). 
All chem icals and enzymes were purchased from 
Sigma Chemica l Co. (St. Louis, Missouri) and were of 
the highest purity ava ilab le. The crysta llin e proteins 
(a ldolase, ,.glycerophosphate dehydrogenase. a nd tr i-
osephosphate isomerase) used as aux ilia ry enzymes were 
dia lyzed before use aga inst 300 vo lumes of 10 mM Tris-
HCI buffer, pH 7.5, for 2 to 3 hours since contamination 
by ammonium ion greatly affects the kinetic properti es 
of t he purified PFK. 
RESU LTS 
T he results of t he partia l purifi cation a re sum -
marized in Table I, a nd the elut ion pattern of 
PFK obtained by ammonium sulfate precipita-
tion (35 to 50% saturatiq n) is shown in Figure 1. 
These s imple procedures yielded a product 50 
times purified , which was adequate for the subse-
quent kinetic studi es. The pH activity curve of 
t he purified PFK is unlike that of t he crude en-
zyme (homogenate) a nd has a sha rper pea k at pH 
8 (Fig. 2) . 
TABLE 
Partial purification of epidermal PFJ( 
- - · 
T utu I Spc · Totnl PF'I( En- ciric Purifi -pro- Protein activ- zymc act iv- cation tcin recovery itv recov - it v factor (mg) (11111;1lc/ cry (SA·J 
min) 
---------- - -
E piderma l 760 LOO 1.5 100 0.002 I 
Homoge nate 
28,000 X 
" 
Su- 130 30 \ .0 66 0.008 4 
pernatant 
-
Ammon ium 30 6.0 .70 46 0.025 13 
Sulfate (35-
50%) 
Sephadex G200 
Fract ion # l2 J.:3 O. l8 .ll 7.:3 0.08 4:2 
Fraction # l3 l. 2 O. l6 .13 8.5 O. ll 53 
Fraction # 14 1. 2 0. 16 . ll 7.2 0.09 46 
·-· ---
*SA ~ ex pressed as 1•moles/min / mg prote in at room 
temperature. 
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FIG. 1. Gel fil t rat ion of epid ermal PFK. The precipi-
tate obta ined at 35 to 50% ammonium sulfate saturation 
was dissolved in AMP buffer, a pplied to a Sephadex G-
200 colu mn. a nd e lu ted as described in ··Materia ls and 
Methods." 
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FIG. 2. pH act ivity curves. On the ord inate, t he en-
zy me act iviti es are expressed as a percentage of the ac-
tiv ity at opti ma l pH. Data on crude enzyme a r·e taken 
from Ref. 19. 
PHOSPHOFRUCTOKINASE: AN ALLOSTERI C ENZYME 399 
In Figures 3 a nd 4, the inhibitory effects of 
ATP are clea rly illustrated. In contrast to our 
previou data wi th the crude enzyme (19) whi ch 
showed a 50% inhibition at a final co ncentrat ion 
of 15 rnM ATP, as littl e as 0.05 to 0.15 mM ATP 
inhibits 50% of the maximal activity of the puri -
fied PFK. These data strongly suggest a s ignifi -
cant role of ATP within its physiologic concentra-
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FIG. 3. Inhibition of epiderm al PFI< by ATP. The 
reaction mixture is described in ··Materials and Meth-
ods" except for different F6P. concentration. 
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FIG . 4. Partial relief of the ATP inhibition by Pi and 
ammonium sulfate. 
tion as a poten t feedback inhibitor. The a ddi t ion 
of ammonium sulfate (10 mM) or Pi (5 mM) acti-
vates PFK and also releases to a great extent the 
feedback inhibitory effects of ATP. 
Adenine nucleotides, such as AMP, ADP, and 
cyclic 3' ,5'- AMP, a lso coun teract t he ATP feed -
back inhibi t ion (Table II) . These modulating ef-
fects are markedly increased by Pi (Table ID but 
not by the simulta neous addition of ADP and 
cyclic 3' ,5' -AMP. These data genera lly con cur 
with those on bra in (20) and sperm (16) PFK. 
The effects of substrate (F6P) concentration on 
PFK activity a re shown in Figure 5. With 400 and 
200 11M ATP in the reaction mixture, a character-
istic s igmoidal curve was obtained. The a ddition 
of cyclic 3' ,5 ' -AMP (1.5 mM) or of Pi (5 mM) 
shifted the sigmoid curve to the hyperboli c curve 
indicative of a shift to first-order kineti cs with 
TABLE II 
Effects of m odulators of A TP inhibition a.n.d synergistic 
s timulatory effec ts 
Add it ion nf modu lo tor 
(fino! cone.) 
Pi (5 mM) 
ADP (1 mM) 
3',5'-AMP (0.5 mM ) 
5'-AMP (2 mM) 
Pi + ADP:j: 
ADP + :3' . 5'-AMP:j: 
Pi + 3',5'-AMP:j: 
Pi + 5'- AMP:j: 
Qbgcrvcd 
rate .. 
(t./minl 
24 
54 
85 
27 
259 
102 
640 
385 
Synerg:ist ic 
eiTec< st 
tfnclor Xl 
3.3 
0 
5.9 
7.5 
* The observed rates were computed as the rate with 
modulator minus the rate without modulator. 
t Synergisti c effects were calculated as (observed 
rate)/(additive ra te). e.g .. (Rate for Pi + ADP) /(Rate for 
Pi + Ra te for ADP) = 259/(24 + 54) = 3.3. 
:j: The final concentra tion of each modulator i ~ the 
same as that in the top colum n. 
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FIG. 5. Allosteric inhibition of epidermal PFK by 
ATP and modulation of this inhibition by cyclic 3' , 5'-
AMP and Pi. 
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F6P. Michae li s consta nts (Km) for F6P deter-
mined by Lineweaver- Burk plots (21) were 6.3 x 
w- • at 0.4 mM ATP fina l concentrat ion and 1.2 
X w-· Mat 0.2 mM ATP; but the a ffini ty for the 
substrate was increased dramatically by the add i-
tion of 1.5 mM cyc li c 3',5'-AMP (with 0.2 mM 
ATP) as indicated by the marked decrease in Km 
to3.4 x 10- •. 
Epiderma l PFK was ma rked ly inhibi ted by cit-
rate (Fig. 6). With 0.1 mM fina l concentrat ion 
about 50% of the maxima l act ivi ty was inhibited . 
The same inhibition at s imilar c itrate concentra-
tion has been reported for yeast (12), brain (22) , 
hea rt (23), musc le (24), liver (25, 26), ad ipose 
tissue (27), and sperm (16) PFK. The cit rate in-
hibi tion of ep iderma l PFK was counteracted by 
cycl ic 3' ,5'-AMP (1.5 mM) , Pi (5 mM) , or 5'-
AMP (2 mM), but we have not attempted any 
further s tudy of the mode of deinhibition of cit-
rate by a denine nucleotides and Pi. 
DISCUSSION 
Our demonstration of the s igmoid curve for 
F6P concentration aga inst the veloc ity of the re-
action is the first of its kind in a skin enzyme 
system and indicates the a llosteric nature of epi -
derma l PFK (for genera l reference on "a lloster-
ism, " cf. Ref. 1) . T he s igmoid nature of the sub-
strate saturation curve does not comply with the 
ordinary Michae lis- Menton formu la, v 
Ymux· [s)/(Km + [s]), which is for a hyperboli c 
curve, but rather conforms to Hill 's formula, v = 
Ymux·[s]"/(Km [s ]"). To obta in " n," the for-
mula is mod ified to 
log (V .. 111 ~ - v) = n log [s ] - log Km; 
thus in the Hill plots (Fig. 7) the coefficient 
va lues (" n" ) for epid erma l PFK a re 1.35 a nd 1.55 
for 0.2 a nd 0.4 mM ATP fina l concentration re-
spectively. According to the definition of Monad 
et a l (9, 10), any " n" va lue larger than 1 indicates 
a llosteric control. The la rge r the " n" va lue, the 
sha rper the s igmoid curve. In our study, for exam-
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FIG. 6. Feedback inhibition of PFK by citrate. 
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FIG. 7. Hil l plots of the sigmoid curves with 0.2, and 
0.4 mM ATP in Fig. 5. See "Discuss ion" for details. 
pi e, t he feedback inhibition of ep iderma l PFK by 
ATP is stronger at 0.4 mM (n = 1.55) t ha n at 0.2 
mM (n = 1.35) and the a dditi on of cyc li c 3', 5'-
AMP released this feedback inhibi t ion with an 
"n" va lue of 1 (since its curve is hyperbolic). 
Thus this decrease in " n" va lue indicates the ac-
tivation of epidermal PFK by the inhibi t ion of 
the a ll oste ri c feed bac k inhibition by ATP. More-
over, 1 < ··n " < 2 indicates so me kind of coop-
erat ive interaction between the enzyme a nd at 
least 2 molecul es of a substrate. 
As discussed previously, t he sigmoid rate 
curve, which is ge nera lly cha racte rist ic of a regu-
latory enzyme, indicates that a s li ght increase (or 
decrease) in the concentrat ion of F6P can result 
in a ma rked increase (or decrease) in the en zyme 
activity. A frequent ly quoted exa mple of such a 
s igmoid curve is that obtained for hemoglob in 
a nd its a ffinity for oxygen (28). The he moglobin is 
completely oxygenated in the lung, where oxygen 
tension is high , a nd is completely deoxygenated 
in peripheral t issue at a low [p0 2 ] . S imila rly, the 
sigmoid curve to r epiderma l PFK indicates the 
s ignifica nt role of t his enzy me in the control of 
glycolysis in the ep id ermis. Thus, when the intra-
cellular concentration of ATP is low (the activ ity 
curve becomes hyperboli c and " n" - · 1) , the a llo-
steric (regu latory) nature of this PFK is de-
creased; but at a hi gh ATP level (the sigmoid 
curve is stren gthened), the regulat01y nature is 
increased so that a minute chan ge in the sub -
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strate level ma rkedly inl1uences t he enzy me ac-
t iv i ty . Over low-con centrat ion ra nges of sub -
stra tes, PFK act ivity increases with t he in -
creasing concent ration of ATP (because of the 
bi nding of ATP, a cofacto r, to t he cata lytic site) ; 
but at higher concen t rat ions, ATP a lso binds at a 
se pa rate regulator s ite and thereby induce a con-
formational cha nge in the enzy me (ref1 ected by 
t h e increase in Km for F6P: 1.2 x 10- ' at 0. 2 mM 
ATP and 6.3 x 10- • at 0.4 mM ATP) a nd the 
con sequent inhibi t ion of enzy me activi ty. Thus 
ATP plays a biphas ic control role. When glucose 
oxidation is excess ive (resul t ing in too much en-
er gy o r ATP), the end product (ATP) signa ls PFK 
to restri ct its ac tivi ty so t hat glycolys is slows 
down . Conversely, the acceleration of glycolys is 
due to t he t ra nsit ion from aerobic to a nae robic 
met a b oli s m (''Pasteur effect" ) would resul t from 
th e activation of PFK following the dec rease in 
th e ra tio of ATP to other adenine nucleotides a nd 
P i. 
Among the modulators of t he ATP feedbac k 
inhibi t ion, cyc li c 3' ,5 '-AMP wa rrants addi t iona l 
comment, since it is now generally acce pted as 
the second messenger of hormone action (29). 
S ince the concentration· required to modulate t he 
ATP inhibi t ion is relat ively hi gh, the phys iologic 
signi f i ca nce of the cAMP effect has been ques-
t io n e d except in such cases as adipose t issue 
PFK, which is ext remely sensitive to cyclic 3', 5'-
AM P (27) a nd muscle PFK, whi ch was activated 
by e pin ephrin e (30). In our epiderma l PFK sys-
te m , t he concentra t ion of cycli c 3', 5' -AMP test ed 
fo r t h e release of t he ATP inhibi t ion was high 
(l o - • M) ; obviously fur ther experiments at lower 
con cen t rations must be conducted to dete rmine 
its phys iologic fun cti on. Nevertheless, the ma rked 
sy n e r g istic effect of cycli c 3',5'-AMP a nd Pi in 
reli eving ATP inhibi t ion (cf. Tabl e II) sugges ts 
that cyclic 3',5'-AMP (toget her wi t h Pi) acts as a 
ph ys io logic modulator of t his regulatory enzy me 
in m o nkey epidermis . 1 
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